Establishment Labs HoldingsESTA -1.86%75 PB Ratio is 170.60 as of Jun. 30, 2026, which is 569% above its 10-year median of 25.51. GuruFocus rates ESTA with a GF Score™ of 75/100 and a GF Value™ of $61.35 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Establishment Labs Holdings ranks worse than 99.87% on this metric.
Establishment Labs Holdings Inc stock PB Ratio (=173.84) is close to 3-year high of 175.71.
The historical rank and industry rank for Establishment Labs Holdings's PB Ratio or its related term are showing as below:
ESTA'
s PB Ratio Range Over the Past 10 Years
Min: 3.03 Med: 25.51 Max: 1145.16
Current: 171.62
During the past 10 years, Establishment Labs Holdings's highest PB Ratio was 1145.16. The lowest was 3.03. And the median was 25.51.
ESTA's PB Ratio is ranked worse than 99.87% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.085
vs ESTA: 171.62
During the past 12 months, Establishment Labs Holdings's average Book Value Per Share Growth Rate was -62.30% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Establishment Labs Holdings was -4.30% per year. The lowest was -39.50% per year. And the median was -15.00% per year.
Back to Basics: PB Ratio
Establishment Labs Holdings (NAS:ESTA) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Establishment Labs Holdings PB Ratio Related Terms
Establishment Labs Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Establishment Labs Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Establishment Labs Holdings PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Establishment Labs Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Establishment Labs Holdings (ESTA) has a PB Ratio of 170.60 as of Jun. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Establishment Labs Holdings and its competitors. This is 569% above median its historical median of 25.51. Over the past decade, Establishment Labs Holdings' PB Ratio has ranged from 3.03 to 1,145.16. According to the industry distribution chart, Establishment Labs Holdings ranks #785 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 99.9%.
Is Establishment Labs Holdings' PB Ratio too high?
Establishment Labs Holdings' current PB Ratio of 170.60 is 569% above median its 10-year median of 25.51. Over the past 10 years, this metric has ranged from a low of 3.03 to a high of 1,145.16. The Medical Devices & Instruments industry median PB Ratio is 2.09. Establishment Labs Holdings' value of 170.60 is 8082.3% above this industry median. Based on the distribution chart, Establishment Labs Holdings ranks #785 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Establishment Labs Holdings has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Establishment Labs Holdings' PB Ratio compare to AXGN and TMDX?
According to the Medical Devices & Instruments industry distribution chart, Establishment Labs Holdings ranks #785 out of 786 companies for PB Ratio. This places Establishment Labs Holdings in the lower half of its industry. The industry median PB Ratio is 2.09. Establishment Labs Holdings' value of 170.60 is 8082.3% above this benchmark. Historically, Establishment Labs Holdings' own PB Ratio has ranged from 3.03 to 1,145.16 over the past decade. While the company's 10-year median is 25.51 vs. the industry median of 2.09, Establishment Labs Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.09, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Establishment Labs Holdings's current PB Ratio of 170.60 is 8082.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Establishment Labs Holdings and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Establishment Labs Holdings's current PB Ratio is 170.60, which is 569% above median its own 10-year median of 25.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Establishment Labs Holdings stock overvalued right now?
Based on GuruFocus' analysis, Establishment Labs Holdings (ESTA) is currently considered Significantly Overvalued. The stock's GF Value™ is $61.35, compared to a current price of $85.81 — trading 39.9% above its estimated fair value. The current PB Ratio is 170.60, which is 569% above median its 10-year median of 25.51 and 8082.3% above the Medical Devices & Instruments industry median of 2.09. Establishment Labs Holdings' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Establishment Labs Holdings (ESTA), the current PB Ratio is 170.60 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Establishment Labs Holdings (ESTA) Overvalued in 2026?
Based on GuruFocus' analysis, Establishment Labs Holdings stock appears to be overvalued.
The current stock price of $85.81 is trading 39.9% above its estimated GF Value™ of $61.35.
GuruFocus considers Establishment Labs Holdings to be Significantly Overvalued.
Key valuation signals for ESTA:
PB Ratio: 170.60 (569% above median its 10-year median of 25.51)
GF Value™: $61.35 vs. price of $85.81 (39.9% above fair value)
Industry Position: 8082.3% above the Medical Devices & Instruments median (#785 of 786)
No single metric tells the full story. See the ESTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
75GF Score
Get the complete analysis for ESTA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESTA has been successfully added to your 
